A Phase II Trial of Anti-CD11/CD18 Monoclonal Antibody in Acute Exacerbations of Multiple Sclerosis.

TitleA Phase II Trial of Anti-CD11/CD18 Monoclonal Antibody in Acute Exacerbations of Multiple Sclerosis.
Publication TypeJournal Article
1999
AuthorsBowen JD, Lublin F
Corporate AuthorsStudy Group Hu23F2G
JournalNeurology
Volume52
IssueSuppl 2
PaginationA290--1
10218066
*Nervous System, *Nervous System Diseases, *Neurology, Animals, Humans, Yes
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10218066

Sign up!

We'll send you a regular email newsletter keeping you informed of what's happening at the MSRRTC.

Send us a message to sign-up. 

Studies Seeking Volunteers:

Currently there are no MSRRTC studies seeking volunteers.

Please check the Dept. of Rehabilitation Medicine's website for other studies on Multiple Sclerosis.